Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden
· Delayed Price · Currency is SEK 49.50
+1.30 (2.70%)
Apr 23, 2025, 5:19 PM CET
STO:IBT.B Revenue
In the year 2024, Infant Bacterial Therapeutics AB had annual revenue of 4.00K SEK, down -94.81%. Infant Bacterial Therapeutics AB had revenue of -1.00K in the quarter ending December 31, 2024.
Revenue
4.00K
Revenue Growth
-94.81%
P/S Ratio
166,708.82
Revenue / Employee
500.00
Employees
8
Market Cap
666.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 898.73M |
| Vimian Group AB | 4.29B |